Posts in: press release

Video interview: Cayman Chemical validates eXoZymes' technology and scalability
press releasenutraceuticalsmedicinevideo
Video interview: Successful pilot scale run with Cayman Chemical validates eXoZymes' technology and scalabilityMarch 18, 2026
2026 MISTA Symposium Healthspan
press releasenutraceuticalsmedicine
eXoZymes’ CCO Damien Perriman to Present a NCT solution at next week’s MISTA SymposiumMarch 12, 2026
With refreshed brand eXoZymes sharpens pharmaceutical focus to drive platform leverage and long-term value creation
press releaseinvestor
With refreshed brand eXoZymes sharpens pharmaceutical focus to drive platform leverage and long-term value creationFebruary 10, 2026
Pharma-grade NCT ready for partner testing
press releaseinvestornutraceuticalsscience
eXoZymes advancing commercial readiness with profound production metrics on initial NCT pilot runJanuary 29, 2026
100× scale-up of NCT production achieved
press releaseinvestornutraceuticalsmedicine
eXoZymes achieves 100× scale-up of NCT production using exozymes, demonstrating near-perfect feedstock conversionDecember 11, 2025
EXOZ 2025 Q3 Update
press releaseinvestor
eXoZymes provides third quarter 2025 update at 5PM EST todayNovember 13, 2025
CSO Tyler Korman - and Chief of Staff, Amy Lunzer
talentpress releaseinvestor
eXoZymes announces cell-free biomanufacturing pioneer, Tyler Korman, as CSO & Amy Lunzer as Chief of StaffNovember 13, 2025
2025 Q3 Earnings Call
press releaseinvestor
eXoZymes to host third quarter 2025 update on Thursday November 13, 2025, at 5PM ESTNovember 10, 2025
CCO Damien Perriman and co-founder and VP of Development, Dr. Paul Opgenorth.
press releasescience
Driving the cell-free revolution: eXoZymes leaders join BioMADE Leadership & Technical CommitteesSeptember 30, 2025
eXoZymes provides second quarter 2025 update at 5PM EST today
press releaseinvestor
eXoZymes provides second quarter 2025 update at 5PM EST todayAugust 12, 2025
Previous page
Page 1 of 4
Next page